Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
Germline genetic testing results informed clinical recommendations for patients with prostate cancer, especially in patients with positive results. Higher than anticipated rates of clinical management changes in patients with uncertain results highlight the need for increased genetic education of clinicians treating patients with prostate cancer.
Authors
- Laurence Belkoff (ORCID: https://orcid.org/0000-0003-2789-6815)
- Edward D. Esplin (ORCID: https://orcid.org/0000-0001-9205-3756)
- Joseph Veys
- Richard Bevan-Thomas
- Paige Layman
- Christopher Pieczonka (ORCID: https://orcid.org/0000-0002-2531-7587)
- Gautam Jayram
- Rachel E. Ellsworth (ORCID: https://orcid.org/0000-0003-2287-1635)
- David Cahn (ORCID: https://orcid.org/0000-0003-0533-4707)
- Paul Dato
- Sarah M. Nielsen (ORCID: https://orcid.org/0000-0002-5916-6393)
- Mary Kay Hardwick
- Susan Rojahn (ORCID: https://orcid.org/0000-0001-5888-7693)
- Charles Idom
- Brandie Heald (ORCID: https://orcid.org/0000-0003-4227-3675)
- Aaron J. Berger (ORCID: https://orcid.org/0000-0002-0359-6773)
- Kathryn E. Hatchell (ORCID: https://orcid.org/0000-0003-0849-7018)
- David R. Wise (ORCID: https://orcid.org/0000-0003-3419-4723)
- Alexander Engelman (ORCID: https://orcid.org/0000-0003-2569-3336)
- Sean Heron
- Neal D. Shore (ORCID: https://orcid.org/0000-0001-5767-0548)
- David S. Morris (ORCID: https://orcid.org/0000-0001-9054-6899)
- Brian C. Mazzarella (ORCID: https://orcid.org/0000-0003-0349-7879)
- Mukaram Gazi
- Robert L. Nussbaum
Institutions
- University of California, San Francisco (US)
- SUNY Upstate Medical University (US)
- Genesis HealthCare (US)
- NYU Langone Health (US)
- Georgia Urology (US)
- Urology Associates (US)
- Genesis Healthcare (US)
- Syracuse VA Medical Center (US)
- Dermatology Specialists (US)
- Invitae (United States) (US)
- Carolina Urologic Research Center (US)
Publication Details
- Journal
- The Journal of Urology
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1097/ju.0000000000004190
- Citations
- 8
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 4.40
Funders
- Amgen
- Bristol-Myers Squibb
- AstraZeneca
- Invitae
- Astellas Pharma